The agency decided the company’s applications fail to show that their products are appropriate for the protection of public health.
Related posts:
Supreme Court agrees to hear first abortion case with 6-3 conservative majority
U.S. must confront Covid spike, noted epidemiologist warns
The most promising coronavirus vaccine you’ve never heard of
Poll: Slim majority in U.S. backs return of masking
HHS unveils office to treat climate change as a health issue
Drug industry banks on its Covid clout to halt Dems’ push on prices
The political fallout of Texas’ abortion ban
The overlooked public health issue that could make or break Biden’s new drug regulator
‘It’s a sore spot for a lot of people’: Why officials are raising questions about Biden’s vaccine donations
U.S. to ask world for more on global Covid fight as its own cash dwindles
Health Secretary Xavier Becerra tests positive for Covid-19
Health official on monkeypox: ‘I feel like this is a virus we understand’
